Indium chloride
As of the edition of 20 October 2026, Indium chloride is a small molecule: marketed, first approved in 1992 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1992
- Kind
- Small molecule
- Brand name
- Indiclor
- First approved
- 29 December 1992 (US)
- Approvals on record
- 2 in 1 region
- Holder of the most recent approval
- Curium; 2 holders in all
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| GE Healthcare | Applicant | 1992 to now |
| Byk-Mallinckrodt CIL | Later holder | 1994 to now |
| Curium | Acquired holder | 2019 to now |